This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
, No Gclids
Disease Info Card
Respiratory Syncytial Virus Bronchiolitis
Information about Respiratory Syncytial Virus Bronchiolitis: characteristics, related genes and pathways, plus antibodies you can use for research. This page is being enriched constantly, if you see some information you would like this page to include please send your suggestions to us.
Overview of Respiratory Syncytial Virus Bronchiolitis
Most recent studies have shown that Respiratory Syncytial Virus Bronchiolitis shares some biological mechanisms with airway-obstruction, asthma, bronchiolitis, bronchiolitis-viral, bronchopulmonary-dysplasia, dysplasia, heart-diseases, infective-disorder, inflammation, lower-respiratory-tract-infection, lung-diseases, pneumonia, respiratory-distress, respiratory-syncytial-virus-(rsv)-infection-in-conditions-classified-elsewhere-and-of-unspecified-site, respiratory-syncytial-virus-infections, respiratory-tract-infections, respirovirus-infections, virus-diseases, wheezing.
Among the many pathways, these few ones have gauged particular interests from scientists studying Respiratory Syncytial Virus Bronchiolitis, and have been seen in publications frequently: Anaphylaxis, Chemotaxis, Cytokine Production, Eosinophil Activation, Excretion, Hormone Secretion, Hypersensitivity, Immune Response, Inflammatory Response, Innate Immune Response, Interleukin-10 Production, Interleukin-12 Production, Neutrophil Activation, Neutrophil Aggregation, Pathogenesis, Response To Lipopolysaccharide, Secretion, Sensitization, Syncytium Formation, Viral Replication
Quite a number of genes have been found to play important roles in Respiratory Syncytial Virus Bronchiolitis, such as CAT, CCL5, CLC, DNASE1, ELANE, GLYAT, IFNG, IL10, IL18, IL2, IL4, IL6, IL9, LBR, MPO, MUC1, RNASE3, TLR4, TNF. See what Boster has to offer for the research of these genes by clicking the gene name links below and view a more detailed info card/product listing for that gene.
In a later update, we will include information such as current drugs and therapy solutions as well as on-going and past clinical trials for this disease. Plesae stay updated.